Compared side by side
HGH vs MK-677: how they differ
The short answer
HGH is recombinant growth hormone itself, injected daily; MK-677 is a small molecule (not a peptide) taken by mouth once a day that mimics ghrelin to boost the body’s own GH pulses and keep IGF-1 raised. HGH is FDA-approved for GH deficiency and several growth disorders, but not for aging or athletic use; in healthy adults, trials show about 2 kg of fat swapped for lean mass. Commonly reported: water retention and tingling hands or fingers on both, and strong hunger on MK-677.
Side by side
| Compared | HGH | MK-677 |
|---|---|---|
| Category | Growth hormone | Growth hormone |
| Also known as | GH, rHGH, Human Growth Hormone, Growth Hormone, Somatropin, hGH | Ibutamoren, Nutrobal, MK677, Ibutamoren Mesylate |
| What it is | Recombinant human growth hormone — an identical copy of the GH your pituitary makes. | Not actually a peptide — it's a small molecule you take orally that mimics ghrelin to stimulate GH release. |
| How it works | Recombinant human growth hormone. Binds GH receptors to stimulate IGF-1 production, protein synthesis, and lipolysis. Promotes muscle growth, fat oxidation, and tissue repair. Structurally identical to pituitary GH, though injections don't reproduce its natural pulses. | Orally active ghrelin receptor agonist and GH secretagogue. Stimulates GH and IGF-1 with little short-term effect on cortisol (a small rise over a year). Its long-lasting effect on GH and IGF-1 allows once-daily oral dosing. Significantly increases appetite and promotes deep sleep. MK-677 is a small molecule GH secretagogue, not a peptide — included because it is extremely commonly tracked alongside peptide GH protocols. |
| Commonly reported | Water retention, numb or tingling fingers, joint aches, and better sleep and skin. Requires careful dosing and IGF-1 monitoring — more is not always better. | Strong hunger, especially in the first weeks; water retention with puffy hands and feet or tingling hands; and deeper sleep with vivid dreams, sometimes with morning grogginess. Once-daily dosing boosts natural GH pulses and keeps IGF-1 elevated. |
| Studied range | Research range: 1–4 IU. Studied in research — not a recommendation. | Research range: 10–25 mg, starting dose 10 mg. Studied in research — not a recommendation. |
| How often | Daily SubQ injection. | Daily, before bed |
| Half-life | ~3-4 hours (SubQ) | ~24 hours (community estimate; no half-life has been published for people: in dogs it was 4–6 hours, and its effect on GH and IGF-1 lasts about a day) |
| Route | SubQ injection | Oral |
| Typical run | Commonly reported starting dose 1-2 IU daily. Advanced users may run 3-4 IU split AM/PM. Cycles of 3-6+ months common. Monitor IGF-1 levels. Also run alongside peptide stacks; some advanced protocols add insulin, which isn't in this library. | Continuous use common (oral convenience). Some cycle 3 months on / 1 month off. Long-term safety data limited. |
| Evidence | Established: clinical trials or FDA-approved use exists | Moderate: animal studies + some human data |
| Common side effects | Water retention, joint pain, carpal tunnel syndrome, morning fatigue, injection site reactions | Increased appetite, water retention, lethargy, elevated fasting glucose, vivid dreams, carpal tunnel symptoms |
- Category
- HGHGrowth hormone
- MK-677Growth hormone
- Also known as
- HGHGH, rHGH, Human Growth Hormone, Growth Hormone, Somatropin, hGH
- MK-677Ibutamoren, Nutrobal, MK677, Ibutamoren Mesylate
- What it is
- HGHRecombinant human growth hormone — an identical copy of the GH your pituitary makes.
- MK-677Not actually a peptide — it's a small molecule you take orally that mimics ghrelin to stimulate GH release.
- How it works
- HGHRecombinant human growth hormone. Binds GH receptors to stimulate IGF-1 production, protein synthesis, and lipolysis. Promotes muscle growth, fat oxidation, and tissue repair. Structurally identical to pituitary GH, though injections don't reproduce its natural pulses.
- MK-677Orally active ghrelin receptor agonist and GH secretagogue. Stimulates GH and IGF-1 with little short-term effect on cortisol (a small rise over a year). Its long-lasting effect on GH and IGF-1 allows once-daily oral dosing. Significantly increases appetite and promotes deep sleep. MK-677 is a small molecule GH secretagogue, not a peptide — included because it is extremely commonly tracked alongside peptide GH protocols.
- Commonly reported
- HGHWater retention, numb or tingling fingers, joint aches, and better sleep and skin. Requires careful dosing and IGF-1 monitoring — more is not always better.
- MK-677Strong hunger, especially in the first weeks; water retention with puffy hands and feet or tingling hands; and deeper sleep with vivid dreams, sometimes with morning grogginess. Once-daily dosing boosts natural GH pulses and keeps IGF-1 elevated.
- Studied range
- HGHResearch range: 1–4 IU. Studied in research — not a recommendation.
- MK-677Research range: 10–25 mg, starting dose 10 mg. Studied in research — not a recommendation.
- How often
- HGHDaily SubQ injection.
- MK-677Daily, before bed
- Half-life
- HGH~3-4 hours (SubQ)
- MK-677~24 hours (community estimate; no half-life has been published for people: in dogs it was 4–6 hours, and its effect on GH and IGF-1 lasts about a day)
- Route
- HGHSubQ injection
- MK-677Oral
- Typical run
- HGHCommonly reported starting dose 1-2 IU daily. Advanced users may run 3-4 IU split AM/PM. Cycles of 3-6+ months common. Monitor IGF-1 levels. Also run alongside peptide stacks; some advanced protocols add insulin, which isn't in this library.
- MK-677Continuous use common (oral convenience). Some cycle 3 months on / 1 month off. Long-term safety data limited.
- Evidence
- HGHEstablished: clinical trials or FDA-approved use exists
- MK-677Moderate: animal studies + some human data
- Common side effects
- HGHWater retention, joint pain, carpal tunnel syndrome, morning fatigue, injection site reactions
- MK-677Increased appetite, water retention, lethargy, elevated fasting glucose, vivid dreams, carpal tunnel symptoms
Typical run: Community practice — opinions vary. Not a clinical recommendation.

Week by week
Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.
HGH
Week-by-week cards for HGH are not in our library.
MK-677
- Day 1–14 Hunger up, sleep deeper, water on
- Day 14–56 Lean mass is climbing
- Day 56–90 Check your labs — glucose is the watch item
Questions people ask
How long do HGH and MK-677 last?
The half-life of HGH is ~3-4 hours (SubQ). The half-life of MK-677 is ~24 hours (community estimate; no half-life has been published for people: in dogs it was 4–6 hours, and its effect on GH and IGF-1 lasts about a day).
How often are HGH and MK-677 taken?
HGH: daily SubQ injection. Route: SubQ injection. MK-677: daily, before bed. Route: Oral.
How are HGH and MK-677 dosed in research?
The research range for HGH is 1–4 IU. The research range for MK-677 is 10–25 mg, with a 10 mg starting dose. Studied in research — not a recommendation.
What are the common side effects of HGH and MK-677?
For HGH, the library lists: water retention, joint pain, carpal tunnel syndrome, morning fatigue, injection site reactions. For MK-677: increased appetite, water retention, lethargy, elevated fasting glucose, vivid dreams, carpal tunnel symptoms.